Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

3.8K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
3.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Cancer Vaccines01:30

Cancer Vaccines

936
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936
Uterus and Cervix01:18

Uterus and Cervix

4.2K
The uterus, commonly called the womb, is a vital reproductive organ in females designed to provide a nurturing environment for the implantation and growth of an embryo. It is shaped like a hollow pear and positioned between the urinary bladder and the rectum. The uterus's structure allows it to support and protect a developing fetus throughout pregnancy.
The uterus is securely anchored within the pelvic cavity by paired broad ligaments on either side. It is further stabilized by three pairs...
4.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

11.1K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Saliva vs Plasma in Liquid Biopsy Sampling for Head and Neck Cancer: A Comparative Study.

Clinical chemistry·2026
Same author

Gynecologic Cancers: Endometrial Cancer.

FP essentials·2025
Same author

Gynecologic Cancers: Ovarian Cancer.

FP essentials·2025
Same author

Gynecologic Cancers: Vulvar Cancer.

FP essentials·2025
Same author

Extracellular Matrix-MYCAF Signatures Correlate with Resistance to Neoadjuvant aPD-L1 Immune Checkpoint Inhibition with Durvalumab + Metformin in HPV+ HNSCC.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

Bridging the gap: associations of provider enrollment in OKCAPMAP with social deprivation, child abuse, and barriers to access in the state of Oklahoma, USA.

Journal of osteopathic medicine·2025

Related Experiment Video

Updated: Jan 11, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.6K

Gynecologic Cancers: Cervical Cancer.

Bindusri Paruchuri1, Amanda Miller1

  • 1Department of Family Medicine at the University of Tennessee Health Science Center, College of Medicine- Nashville, TN.

FP Essentials
|November 18, 2025
PubMed
Summary
This summary is machine-generated.

Cervical cancer, a preventable disease, requires focus on risk factors like human papillomavirus (HPV) infection and encourages vaccination. Early detection through screening and timely referral for advanced treatment improves survival rates.

More Related Videos

Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.6K
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.8K

Related Experiment Videos

Last Updated: Jan 11, 2026

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
09:48

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells

Published on: September 12, 2019

8.6K
Stereotactic Radiosurgery for Gynecologic Cancer
10:35

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

18.6K
Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors
07:01

Obtaining Cancer Stem Cell Spheres from Gynecological and Breast Cancer Tumors

Published on: March 1, 2020

10.8K

Area of Science:

  • Gynecology
  • Oncology
  • Public Health

Background:

  • Cervical cancer is a significant global health concern, particularly in developing nations, and the second most common pregnancy-associated malignancy.
  • While less prevalent in the U.S., its preventability necessitates a focus on risk identification, primary prevention, and early detection strategies.
  • Persistent high-risk human papillomavirus (HPV) infection is the primary risk factor, underscoring the importance of HPV vaccination.

Purpose of the Study:

  • To outline current understanding and management strategies for cervical cancer, emphasizing prevention, screening, and treatment.
  • To highlight the role of HPV vaccination and screening methods in primary and secondary prevention.
  • To discuss diagnostic imaging, staging, and multidisciplinary treatment approaches, including fertility-sparing options.

Main Methods:

  • Review of cervical cancer risk factors, focusing on HPV infection and vaccination.
  • Description of cervical cancer screening modalities: cytology, HPV testing, and cotesting.
  • Outline of diagnostic workup including imaging (MRI, CT, PET) and staging.
  • Discussion of management guidelines, referral protocols, and treatment options (surgery, radiation, chemotherapy, immunotherapy, targeted therapy).

Main Results:

  • The 5-year survival rate for cervical cancer is approximately 68.0%, highly dependent on the stage at diagnosis.
  • Effective management relies on adherence to screening guidelines and prompt referral for advanced disease.
  • Fertility-sparing treatments are viable options for select patients with appropriate counseling.

Conclusions:

  • Cervical cancer management requires a comprehensive approach encompassing prevention, early detection, accurate staging, and tailored treatment.
  • Multidisciplinary care and survivorship planning are crucial for optimizing patient outcomes.
  • Continued emphasis on HPV vaccination and screening is essential for reducing the global burden of cervical cancer.